Dina Michelle Poplausky

Ms. Dina Michelle Poplausky


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2022 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
SOShayan Owji
Shayan Owji
BUBenjamin Ungar
Benjamin Ungar
DDDanielle P. Dubin
Danielle P. Dubin
DPDina Michelle Poplausky
Dina Michelle Poplausky
JYJade N. Young
Jade N. Young
NGNicholas Gulati
Nicholas Gulati

16 May 2023 in Cancers
Verified
Journal Article
Open access
PDF file
DPDina Michelle Poplausky
Dina Michelle Poplausky
JYJade N. Young
Jade N. Young
HTHansen Tai
Hansen Tai
RRRyan Rivera-Oyola
Ryan Rivera-Oyola
NGNicholas Gulati
Nicholas Gulati
Rebecca M BrownRebecca M Brown
Rebecca M Brown
Neurofibromatosis type 1 (NF1) is an autosomal dominant tumor predisposition syndrome that increases one’s risk for both benign and malignant tumors. NF1 affects every organ in the body, but the most distinctive symptoms that are often the most bothersome to patients are the cutaneous manifestations, which can be unsightly, cause pain or pruritus, and have limited therapeutic options. In an effort to increase awareness of lesser-known dermatologic associations and to promote multidisciplinary care, we conducted a narrative review to shed light on dermatologic associations of NF1 as well as emerging treatment options. Topics covered include cutaneous neurofibromas, plexiform neurofibromas, diffuse neurofibromas, distinct nodular lesions, malignant peripheral nerve sheath tumors, glomus tumors, juvenile xanthogranulomas, skin cancer, and cutaneous T-cell lymphoma.

14 December 2023 in JMIR Dermatology
Verified
Journal Article
Open access
RORoss O'HAgan
Ross O'HAgan
DPDina Michelle Poplausky
Dina Michelle Poplausky
JYJade N Young
Jade N Young
NGNicholas Gulati
Nicholas Gulati
MLMelissa Levoska
Melissa Levoska
JUJonathan Ungar
Jonathan Ungar

30 January 2023 in Antimicrobial Stewardship & Healthcare Epidemiology
Verified
Journal Article
Open access
PDF file
CBCassidy Boomsma
Cassidy Boomsma
DPDina Michelle Poplausky
Dina Michelle Poplausky
JJJacob M. Jasper
Jacob M. Jasper
MMMacKenzie Clark MacRae
MacKenzie Clark MacRae
ATAlice M. Tang
Alice M. Tang
RSRamnath Subbaraman
Ramnath Subbaraman
Objective: Hospital employees are at risk of SARS-CoV-2 infection through transmission in 3 settings: (1) the community, (2) within the hospital from patient care, and (3) within the hospital from other employees. We evaluated probable sources of infection among hospital employees based on reported exposures before infection. Design: A structured survey was distributed to participants to evaluate presumed COVID-19 exposures (ie, close contacts with people with known or probable COVID-19) and mask usage. Participants were stratified into high, medium, low, and unknown risk categories based on exposure characteristics and personal protective equipment. Setting: Tertiary-care hospital in Boston, Massachusetts. Participants: Hospital employees with a positive SARS-CoV-2 PCR test result between March 2020 and January 2021. During this period, 573 employees tested positive, of whom 187 (31.5%) participated. Results: We did not detect a statistically significant difference in the proportion of employees who reported any exposure (ie, close contacts at any risk level) in the community compared with any exposure in the hospital, from either patients or employees. In total, 131 participants (70.0%) reported no known high-risk exposure (ie, unmasked close contacts) in any setting. Among those who could identify a high-risk exposure, employees were more likely to have had a high-risk exposure in the community than in both hospital settings combined (odds ratio, 1.89; P = .03). Conclusions: Hospital employees experienced exposure risks in both community and hospital settings. Most employees were unable to identify high-risk exposures prior to infection. When respondents identified high-risk exposures, they were more likely to have occurred in the community.

28 December 2022 in The Journal of Dermatology
Verified
Journal Article
Closed access
JHJoseph Han
Joseph Han
SSScott Stratman
Scott Stratman
JYJade N. Young
Jade N. Young
DPDina Michelle Poplausky
Dina Michelle Poplausky
SOShayan Owji
Shayan Owji
NGNicholas Gulati
Nicholas Gulati

12 June 2023 in JMIR Preprints
Verified
Preprint
Open access
RORoss O'Hagan
Ross O'Hagan
DPDina Michelle Poplausky
Dina Michelle Poplausky
JYJade N Young
Jade N Young
NGNicholas Gulati
Nicholas Gulati
MLMelissa Levoska
Melissa Levoska
JUJonathan Ungar
Jonathan Ungar
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).